Achyut Healthcare Limited (ACHYUT.BO)
INR 3.25
(4.84%)
INR 3.25
(4.84%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 5.73 Million INR | 147.92% |
| 2022 | 2.31 Million INR | 473.7% |
| 2021 | 403 Thousand INR | 444.59% |
| 2020 | 74 Thousand INR | -47.14% |
| 2019 | 140 Thousand INR | 195.89% |
| 2018 | -146 Thousand INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 3.52 Million INR | 0.0% |
| 2023 Q1 | 1.3 Million INR | 1517.39% |
| 2023 Q4 | 3.12 Million INR | 100.0% |
| 2023 Q2 | 2.6 Million INR | 100.0% |
| 2023 FY | 5.73 Million INR | 147.92% |
| 2023 Q3 | 1.56 Million INR | -40.11% |
| 2022 Q3 | -45.5 Thousand INR | -103.79% |
| 2022 Q2 | 1.2 Million INR | 0.0% |
| 2022 FY | 2.31 Million INR | 473.7% |
| 2022 Q1 | 1.2 Million INR | 340.79% |
| 2022 Q4 | -92 Thousand INR | -102.2% |
| 2021 Q1 | 631.5 Thousand INR | 0.0% |
| 2021 FY | 403 Thousand INR | 444.59% |
| 2021 Q4 | -498.98 Thousand INR | -100.4% |
| 2021 Q3 | -249 Thousand INR | -127.62% |
| 2021 Q2 | 901.68 Thousand INR | 42.78% |
| 2020 FY | 74 Thousand INR | -47.14% |
| 2019 FY | 140 Thousand INR | 195.89% |
| 2018 FY | -146 Thousand INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 99.907% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 99.982% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 99.878% |
| Granules India Limited | 4.05 Billion INR | 99.859% |
| Indoco Remedies Limited | 984.6 Million INR | 99.418% |
| Ajanta Pharma Limited | 8.16 Billion INR | 99.93% |
| Alkem Laboratories Limited | 17.95 Billion INR | 99.968% |
| Alpa Laboratories Limited | 167.76 Million INR | 96.583% |
| Brooks Laboratories Limited | -195.91 Million INR | 102.926% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | 99.645% |
| Bajaj HealthCare Limited | -837.93 Million INR | 100.684% |
| Bliss GVS Pharma Limited | 754.54 Million INR | 99.24% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 99.99% |
| Eris Lifesciences Limited | 3.91 Billion INR | 99.854% |
| FDC Limited | 3.05 Billion INR | 99.812% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 100.038% |
| Gufic Biosciences Limited | 861.35 Million INR | 99.335% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 99.864% |
| Ipca Laboratories Limited | 5.47 Billion INR | 99.895% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | 97.448% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 102.905% |
| Lasa Supergenerics Limited | -217.3 Million INR | 102.638% |
| Laurus Labs Limited | 1.6 Billion INR | 99.643% |
| Lupin Limited | 19.14 Billion INR | 99.97% |
| Mankind Pharma Limited | 19.12 Billion INR | 99.97% |
| Medicamen Biotech Limited | 109.31 Million INR | 94.756% |
| Medico Remedies Limited | 82.9 Million INR | 93.086% |
| Megasoft Limited | -127.46 Million INR | 104.497% |
| NATCO Pharma Limited | 13.88 Billion INR | 99.959% |
| Piramal Pharma Limited | 178.2 Million INR | 96.783% |
| RPG Life Sciences Limited | 876.6 Million INR | 99.346% |
| Sigachi Industries Limited | 571.8 Million INR | 98.998% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 99.994% |
| Suven Pharmaceuticals Limited | 3 Billion INR | 99.809% |
| Syncom Formulations (India) Limited | 253.14 Million INR | 97.736% |
| Unichem Laboratories Limited | -704.74 Million INR | 100.813% |
| Wanbury Limited | 559.56 Million INR | 98.976% |
| Windlas Biotech Limited | 581.87 Million INR | 99.015% |
| ZIM Laboratories Limited | 172.46 Million INR | 96.676% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 99.985% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 100.148% |
| Divi's Laboratories Limited | 16 Billion INR | 99.964% |
| Hester Biosciences Limited | 188.89 Million INR | 96.965% |
| Procter & Gamble Health Limited | 2 Billion INR | 99.715% |
| Amrutanjan Health Care Limited | 449.72 Million INR | 98.725% |
| Bal Pharma Limited | 73.92 Million INR | 92.246% |
| Strides Pharma Science Limited | -706.14 Million INR | 100.812% |
| Venus Remedies Limited | 284.9 Million INR | 97.988% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | 99.736% |
| Nectar Lifesciences Limited | 49.95 Million INR | 88.525% |
| Shilpa Medicare Limited | 318.74 Million INR | 98.202% |
| Aarti Drugs Limited | 1.71 Billion INR | 99.666% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 99.574% |
| Suven Life Sciences Limited | -1.05 Billion INR | 100.546% |
| Ind-Swift Limited | 142.31 Million INR | 95.972% |
| Valiant Laboratories Limited | 3.19 Million INR | -79.349% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 99.896% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 100.101% |
| Themis Medicare Limited | 435.23 Million INR | 98.683% |
| Hikal Limited | 696.02 Million INR | 99.176% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 99.965% |
| Sequent Scientific Limited | -358.69 Million INR | 101.598% |
| Novartis India Limited | 851.9 Million INR | 99.327% |
| Wockhardt Limited | -4.63 Billion INR | 100.124% |
| Jubilant Pharmova Limited | 771 Million INR | 99.257% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | 19.177% |
| Neuland Laboratories Limited | 3 Billion INR | 99.809% |
| Morepen Laboratories Limited | 961.59 Million INR | 99.404% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | 96.074% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 106.319% |